Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

NCT00943592 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hematologic Malignancies
Leukemia
Preleukemia

Interventions

DRUG: Clofarabine
DRUG: Melphalan
DRUG: Campath
PROCEDURE: Stem Cell Transplant

Sponsor

University of Chicago